Premium CJC-1295 With DAC 5mg for Research | Lyophilized Powder | Research-Use-Only Peptide | EU & UK Delivery
CJC-1295 With DAC 5mg: Research Compound for Growth Hormone & Endocrine Signaling Studies
peptology.store presents CJC-1295 With DAC 5mg, a synthetic growth hormone–releasing hormone (GHRH) analog incorporating a Drug Affinity Complex (DAC). This research compound is investigated for its interaction with GHRH receptor signaling and its potential effects on the growth hormone (GH)/IGF-1 axis. It is supplied strictly for laboratory and research use.
CJC-1295 With DAC was developed as a longer-acting GHRH analog designed to extend the peptide’s biological persistence compared with conventional short-acting GHRH compounds. Its extended activity makes it a useful research tool for investigating prolonged GHRH receptor stimulation, endocrine signaling, and downstream GH/IGF-1 pathways.
For researchers studying CJC-1295 With DAC 5mg in laboratory settings, peptology.store provides research-use material with product documentation intended to support analytical and experimental workflows. The compound should not be represented as an approved human therapeutic or as being intended for human consumption.
Why CJC-1295 With DAC Matters in Contemporary Research
The scientific interest in CJC-1295 With DAC stems from its ability to investigate prolonged GHRH-related signaling. GHRH is involved in the regulation of growth hormone secretion through interaction with the growth hormone–releasing hormone receptor (GHRHR) on pituitary cells. The DAC modification is intended to increase the persistence of the peptide, providing a model for studying longer-duration receptor signaling.
This mechanism provides applications across several research areas:
Growth Hormone Research: Studies investigate CJC-1295 With DAC as a tool for examining GHRH-mediated regulation of growth hormone secretion and related endocrine pathways.
GH/IGF-1 Axis Research: The compound can be used to investigate relationships between GHRH signaling, GH secretion, and downstream IGF-1-related pathways in controlled experimental models.
Peptide Pharmacology: Researchers can study the pharmacological characteristics of a long-acting GHRH analog, including receptor interaction, biological persistence, and downstream signaling.
Endocrine Research: CJC-1295 With DAC provides a research model for examining prolonged stimulation of pathways associated with the hypothalamic-pituitary-growth hormone axis.
Metabolic & Physiological Research: Because GH-related signaling interacts with multiple physiological systems, researchers may investigate downstream metabolic and cellular responses in appropriate experimental models.
Technical Excellence: Purity, Potency & Quality Assurance
When researching CJC-1295 With DAC 5mg from peptology.store, product identity and purity should be established using appropriate batch-specific analytical documentation. Relevant quality-control information may include:
Chemical Specifications
| Parameter | Specification |
|---|---|
| Product Name | CJC-1295 With DAC |
| Quantity | 5mg |
| Peptide Classification | Synthetic GHRH analog with Drug Affinity Complex (DAC) |
| Purity | Verify using the batch-specific Certificate of Analysis |
| Appearance | Lyophilized peptide powder |
| Storage | Store according to the manufacturer’s batch-specific recommendations, protected from light and moisture |
Mechanism of Action Data
- Target: Growth hormone-releasing hormone receptor (GHRHR)
- Compound Type: Synthetic GHRH analog incorporating a Drug Affinity Complex (DAC)
- Primary Research Focus: GHRH receptor signaling and regulation of the GH/IGF-1 axis
- Pharmacological Characteristic: Designed for extended biological persistence compared with shorter-acting GHRH analogs
Documented Research Activity
CJC-1295 With DAC has been investigated across experimental systems for its effects on growth hormone–related signaling:
- Investigates stimulation of GHRH receptor–mediated signaling
- Used to examine regulation of growth hormone secretion
- Enables investigation of prolonged GHRH-related signaling
- Supports research into downstream GH/IGF-1 pathway activity
- Provides a model for studying the pharmacology of long-acting GHRH analogs
Research Applications & Investigator Guidance
Growth Hormone & Endocrine Research
CJC-1295 With DAC is investigated in studies of growth hormone regulation and endocrine signaling. Its GHRH-related activity makes it relevant for:
- GH signaling research: Investigating mechanisms regulating growth hormone secretion
- GHRHR studies: Examining receptor-mediated signaling pathways
- GH/IGF-1 axis research: Studying relationships between GH signaling and downstream IGF-1 pathways
Peptide Pharmacology Research
The compound provides a model for investigating long-acting peptide pharmacology, including:
- Receptor signaling: Studying GHRH receptor interactions
- Biological persistence: Investigating the extended activity associated with the DAC modification
- Structure-function studies: Examining how peptide modifications influence pharmacological behavior
Endocrine Physiology Research
CJC-1295 With DAC can be investigated in controlled experimental models involving:
- Pituitary signaling: Examining GHRH-mediated endocrine responses
- Hormonal regulation: Studying the regulation of GH-related pathways
- Downstream signaling: Investigating biological processes associated with the GH/IGF-1 axis
Handling, Storage & Stability Guidelines
Proper handling and storage of CJC-1295 With DAC 5mg are essential for maintaining its integrity for research applications.
Storage Recommendations
| Storage Condition | Recommended Handling |
|---|---|
| Lyophilized powder at -20°C | Store sealed, dry, and protected from light and moisture |
| Lyophilized powder at 2–8°C | Suitable for short-term storage when maintained in the original sealed container |
| After reconstitution | Store refrigerated at 2–8°C and minimize exposure to light |
| Long-term reconstituted storage | Aliquot where appropriate and avoid repeated freeze–thaw cycles |
| Stability period | Use the manufacturer’s batch-specific stability/COA data rather than claiming a fixed shelf life |
Preparation Guidelines
For in vitro studies:
- Stock Solution Preparation: Reconstitute CJC-1295 With DAC using a laboratory-appropriate solvent or aqueous vehicle based on the specific experimental protocol and supplier’s solubility data.
- Working Solutions: Dilute the stock solution into the appropriate cell-culture medium or experimental buffer immediately before use.
- Mixing: Gently swirl or roll the vial after adding solvent. Avoid vigorous shaking or excessive foaming.
- Aliquoting: Where appropriate, prepare single-use aliquots to minimize repeated freeze–thaw exposure.
- Documentation: Record the reconstitution date, concentration, solvent, and batch number for reproducibility.
For laboratory in vivo studies:
- Formulation and route of administration should be determined according to the validated animal-study protocol, applicable institutional requirements, and available formulation data for the specific CJC-1295 With DAC material.
- Vehicle selection should account for the compound’s documented solubility and compatibility with the intended experimental system.
- Prepare formulations under appropriate laboratory conditions and use within the validated stability period.
Important: All formulations should be prepared fresh and used immediately for optimal results .
Quality Assurance: Our Commitment to Research Excellence
At peptology.store, we understand that research outcomes depend on compound identity, purity, and material integrity. Every batch of CJC-1295 With DAC 5mg should be supported by appropriate analytical documentation and quality-control procedures, including:
- HPLC purity analysis where applicable
- Mass spectrometry verification for molecular identity and molecular-weight confirmation
- Batch-specific Certificates of Analysis (COA)
- Identity and purity documentation for research traceability
- Storage and handling information appropriate to the supplied formulation
The product should be supplied with documentation that allows qualified researchers to verify the material before incorporating it into laboratory work.
Why Research Professionals Choose peptology.store
Research-Focused Quality Standards
We maintain quality-control procedures designed to support the reproducibility and traceability of CJC-1295 With DAC 5mg research material. Each released batch should be accompanied by appropriate analytical and batch documentation.
Comprehensive Documentation
Researchers can use batch-specific documentation to review reported purity, identity, lot information, and applicable storage recommendations before beginning experimental work.
Research Handling Support
Information concerning storage, preparation, solubility, and laboratory handling should be based on the specific formulation and available analytical documentation rather than assumptions from unrelated compounds.
Key Research Characteristics
- Research-Grade Material: Supplied for laboratory research applications
- Peptide Identity: CJC-1295 With DAC
- Quantity: 5mg
- Analytical Verification: HPLC and/or mass-spectrometry data where available
- Batch Traceability: Lot-specific documentation
- Research-Use Only: Not presented as an approved therapeutic product
- Documentation: COA and applicable analytical information
- Storage Guidance: Follow product-specific manufacturer recommendations
- Handling Guidance: Use appropriate laboratory procedures and institutional safety requirements
Frequently Asked Questions
Q: What is CJC-1295 With DAC?
A: CJC-1295 With DAC is a long-acting peptide research compound investigated primarily in studies involving growth-hormone-related signaling and endocrine physiology. It is supplied here as 5mg research material and is not represented as an approved treatment.
Q: Is CJC-1295 With DAC suitable for human consumption?
A: No. This product is intended strictly for research and laboratory use and should not be marketed or represented as a product for human consumption, self-administration, or therapeutic use.
Q: What purity information is available for CJC-1295 With DAC 5mg?
A: Purity should be stated according to the batch-specific Certificate of Analysis. Where analytical testing has been performed, the applicable HPLC and/or mass-spectrometry documentation should be provided rather than using an unsupported purity claim.
Q: How should CJC-1295 With DAC 5mg be stored?
A: Store the lyophilized material according to the manufacturer’s validated storage recommendations, generally in a sealed, dry environment protected from light and moisture. Avoid unnecessary temperature fluctuations.
Q: How should CJC-1295 With DAC be prepared for research?
A: Preparation should follow the validated laboratory protocol and the specific material’s documented solubility and formulation requirements. Researchers should record the batch number, preparation date, solvent or vehicle, and resulting concentration to support experimental reproducibility.
Q: What documentation should accompany the product?
A: Appropriate documentation may include a batch-specific Certificate of Analysis, purity information, analytical identity data, lot number, and applicable storage/handling instructions.
Q: What research areas are relevant to CJC-1295 With DAC?
A: Research involving CJC-1295 With DAC may examine growth-hormone signaling, IGF-1-related pathways, endocrine physiology, peptide pharmacology, and related experimental models. Findings from preclinical or experimental research should not be presented as established clinical benefits.
Q: Do you ship CJC-1295 With DAC to EU countries?
A: Yes. As a dedicated peptide supplier, we ship CJC-1295 With DAC to all European Union member states with our guaranteed 48 hour delivery peptide service.
Q: What documentation do you provide with CJC-1295 With DAC orders?
A: Each order should include a Certificate of Analysis (COA) containing batch-specific information such as reported purity and product identity. Additional analytical documentation, such as HPLC chromatograms and mass-spectrometry data, may be available upon request.
Q: Is CJC-1295 With DAC a SARM?
A: No. CJC-1295 With DAC is a peptide research compound and is not classified as a selective androgen receptor modulator (SARM). It is investigated primarily in relation to growth-hormone-related signaling and endocrine pathways.
Q: What research areas commonly use CJC-1295 With DAC?
A: CJC-1295 With DAC may be investigated in growth hormone signaling, IGF-1-related research, endocrine physiology, peptide pharmacology, metabolic research, and related preclinical models.
Q: How is CJC-1295 With DAC typically administered in laboratory studies?
A: Administration methods and experimental concentrations should be determined according to the specific research protocol, model, formulation, and institutional requirements. Product-specific instructions should not be inferred from protocols for unrelated compounds.
Q: What is the mechanism of action of CJC-1295 With DAC?
A: CJC-1295 With DAC is an engineered peptide investigated for its ability to influence growth hormone–related signaling. The DAC modification is designed to extend the peptide’s persistence in experimental systems compared with shorter-acting peptide formulations.
Q: Can I use CJC-1295 With DAC for long-term studies?
A: Researchers should establish study duration according to their experimental objectives, available safety and stability data, and applicable institutional protocols. CJC-1295 With DAC is an investigational research compound and should not be presented as an established long-term human therapy.
Q: Do you offer bulk quantities for institutional research?
A: Yes. We accommodate bulk orders for research institutions. Contact our team now for volume pricing and custom requirements.
Q: How is CJC-1295 With DAC shipped to maintain stability?
A: CJC-1295 With DAC powder is shipped at ambient temperature for short transit times (48 hours). Upon receipt, we recommend immediate transfer to -20°C storage for long-term stability.
Q: What is the difference between CJC-1295 With DAC and other growth-hormone-related peptides?
A: CJC-1295 With DAC is distinguished by its drug-affinity complex (DAC) modification, which is designed to extend its persistence compared with shorter-acting CJC-1295 formulations. This makes it a useful research tool for investigating prolonged growth-hormone-related signaling and endocrine responses in experimental models.
Advance Your Research with Premium CJC-1295 With DAC
peptology.store is your trusted source for high-purity CJC-1295 With DAC. Whether you are investigating metabolic pathways, exploring PPARδ biology, or conducting cardiovascular research, our rigorously tested compound provides the quality and consistency your work demands.
Order today and experience the peptology.store difference – premium quality, rapid delivery, and expert support for the European research community.
